MAPT and Alzheimer disease: Interestingly, in the no tau cohort, 33% of cases carrying any type of pTau aggregate have a positive A score, while in the AD tau cohort, 100% of cases carrying nucleolar pTau aggregates have a positive A score (with 90% having A score = 3).